NCT03716011View on ClinicalTrials.gov

A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT

NANot yet recruitingINTERVENTIONAL
Enrollment

2,700

Participants

Timeline

Start Date

December 20, 2018

Primary Completion Date

December 20, 2021

Study Completion Date

December 20, 2025

Conditions
Coronary Artery Disease
Interventions
DEVICE

EXCROSSAL

a Second Generation Biodegradable Polymer Sirolimus-Eluting Stent

Trial Locations (1)

100029

JW Medical System, Beijing

Sponsors
All Listed Sponsors
lead

JW Medical Systems Ltd

INDUSTRY